Irregular heart rhythm disorder refers to repeated or uncontrollable heart attacks after treatment with a prescribed anti-cardiovascular abnormality, mainly involving uncontrollable cardiac arrhythmias, uncontrollable atrial fibrillation, congestive heart failure, and cell blockage. Irregular heart rhythm disorder refers to the origin of heart rhythms, frequency, rhythm or transmission of abnormalities, mild discomfort in people who are only feeling uncomfortable, who are overweight can cause blood circulation disorders, heart failure, stroke, or even cardiac death. Irregular heart rhythm disorder patients tend to have repeated symptoms, are frequent, and require individualized integrated management strategies.
Coronary heart disease (coronary heart disease, heart attack, cardiomyopathy, cardiomyopathy, coronary artery disease) is the most common cause, and heart muscle scar tissue or fibromyalgia is a 'pathogen' of abnormal heart rhythm; electrolyte disorders (low blood pressure, low blood pressure), thyroid dysfunction, opioid narcotics, some anti-arrhythmic drugs) can also be induced or exacerbated; autonomic neurological disorders, mental tension, excess fatigue, and caffeinated stimulants are also involved. The clinical outcome of an incurable heart rhythm abnormality depends on the type of heart rhythm abnormality and its effect on blood circulation. Cerebral palsy can cause panic, heart palsy, chest pains, heartbeat 'slip' or 'slip'; rapid heart rhythm abnormality can lead to dizziness, haemorrhage, weakness, severe dizziness, asthma syndrome; chronic heart rhythm failure (commonly severe atrial fibrillation, high chamber conduction obstruction) can lead to a lack of blood supply to the brain, headache, dizziness, and dizziness.
Cerebral palsy can also increase the risk of blood clots and stroke. Diagnosis of irregular heart rhythms relies on cardiac electrograms, including conventional cardiac electrograms, 24-hour dynamic cardiac electrograms (Holter, capture of myocardial infarction), long-range cardiac electromagnetic monitoring; cardiac ultrasound to assess cardiac structure and function when necessary; cardiac magnetic resonance imaging, coronary artery imaging to determine the exact cause of the disease; electrophysical examination (cardiothoracic electrophysical scanning) is a key examination to determine the mechanism of cardiac abnormalities and guide digestive therapy. At the same time, electrolytes, thyroid function, etc.
Treatment of irregular heart rhythms with a curative heart rhythm should emphasize 'removal of inducing + drugs + non-drugs'. First, actively treat the original disease, correct the electrolyte disorder, stop the use of cardiovascular abnormalities. In pharmacological treatment, different types of anti-cardiovascular abnormalities (cardiovascular blockers, β-receptor blockers, cardiovascular blockers, cardiovascular blockers, etc.
) target different mechanisms, the untreated often need to combine or replace medications, and be wary of the cardiovascular abnormalities of the drugs themselves. Non-drug therapy is a major advance in modern treatment: directed radiation frequency decomposition: finding and elimination of disease through cardiac electrocardiogrammetry; rapid cardiac abnormalities, cardiac abnormalities, upper chamber velocity, chamber velocity), are currently important root remedies; Implanted heart rhythm transplants (ICD) can automatically identify and terminate malignant chamber cysts, which are key measures to prevent cardiac arrhythmias; slow heart rhythm abnormalities are implanted in cardiac arrhythmias. Patients with cardiac arrhythmias also need to decide whether they are resistant to congestive heart failure treatment based on a stroke risk assessment.
The development of modern electro-physical technology has provided an increasing number of treatment opportunities for irritable bowel syndrome, with the majority of patients receiving good control and improving prognosis through comprehensive treatment.
[!--page.url--]